Tech Company Financing Transactions
Meditrina Pharmaceuticals Funding Round
Meditrina Pharmaceuticals, based in San Jose, raised $5 million from Horizon Technology Finance.
Transaction Overview
Company Name
Announced On
5/9/2019
Transaction Type
Debt
Amount
$5,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company will use the proceeds for further development and accelerate commercial activities of the Aveta system.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1190 Saratoga ave. 180
San Jose, CA 95129
USA
San Jose, CA 95129
USA
Phone
Website
Email Address
Not Recorded
Overview
Meditrina Pharmaceuticals, Inc. identifies and repurposes already marketed therapies and product candidates at advanced stages of development for new indications focused on improving women's health disorders with unmet medical needs.
Management Team
Browse more venture capital transactions:
Prev: 5/9/2019: DispatchHealth venture capital transaction
Next: 5/9/2019: Neural Analytics venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs